微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -0.07% | -108.54% | 97.35% | 33/51 | 0.99% | 澳洋健康 | 12.87% | 行业排名> |
| 2024-12-31 | -2.64% | -210.46% | -246.67% | 32/51 | -1.19% | 澳洋健康 | 28.53% | 行业排名> |
| 2024-09-30 | 1.8% | -34.31% | 1185.71% | 29/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 0.14% | -80.56% | -82.93% | 35/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 0.82% | -6.82% | -65.69% | 26/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 2.39% | -28.87% | -12.77% | 32/51 | 3.7% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 2.74% | -40.56% | 280.56% | 35/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 0.72% | -71.2% | -18.18% | 36/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 0.88% | -45.68% | -73.81% | 34/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 3.36% | -82.86% | -27.11% | 31/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 4.61% | -67.78% | 84.4% | 31/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 2.5% | -76.33% | 54.32% | 33/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 1.62% | 2% | -91.73% | 24/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 19.6% | -18.2% | 36.97% | 13/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 14.31% | 2% | 35.51% | 11/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 10.56% | -9.04% | -55.93% | 13/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2020-12-31 | 23.96% | 49.38% | 106.37% | 12/51 | 10.95% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-06-30 | 11.61% | 2% | -27.62% | 4/51 | 2.48% | 金域医学 | 13.23% | 行业排名> |
| 2019-12-31 | 16.04% | 491.88% | 491.88% | 18/51 | 65.31% | 万邦医药 | 52.05% | 行业排名> |
| 2018-12-31 | 2.71% | 25.46% | 25.46% | 35/51 | -0.6% | 华大基因 | 48.52% | 行业排名> |
| 2017-12-31 | 2.16% | 2% | 2% | 34/51 | 1.73% | 华大基因 | 31.24% | 行业排名> |